Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Zyga Technology raises $25mm in Series C round

Executive Summary

Zyga Technology Inc. (minimally invasive surgical solutions for the spine) has raised $25mm in a Series C financing led by first-time backer Versant Ventures, which adds a board member and was joined by returning shareholders Domain Associates, MB Venture Partners, and Split Rock Partners. Funds will support commercialization activities for its SImmetry sacroiliac joint fusion system and ongoing clinical development of the Glyder facet resurfacing device.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register